WATSON 746
Pill imprint WATSON 746 has been identified as Clonazepam 0.5 mg.
Clonazepam is used in the treatment of anxiety; bipolar disorder; panic disorder; seizure prevention; periodic limb movement disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy.
Clonazepam 0.5 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Clonazepam Images
- Imprint:
-
WATSON 746
- Strength:
- 0.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- docusate sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
- Drug Class:
- Benzodiazepine anticonvulsants
Benzodiazepines - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0746
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0599 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Clonazepam resources
- Clonazepam
- Clonazepam (Wolters Kluwer)
- Clonazepam Orally Disintegrating Tablets (Wolters Kluwer)
- clonazepam (Cerner Multum)
- clonazepam (Micromedex) - Includes Dosage Information
- Clonazepam (AHFS DI)
- Clonazepam (FDA)
- Clonazepam Tablet Orally Disintegrating (FDA)
- Clonazepam (Wolters Kluwer)
Search Again
